Penumbra Inc. Daily Stock Analysis

Daily Stock Analysis, PEN, Penumbra Inc, priceseries

Penumbra Inc. Daily Stock Analysis
Stock Information
Open
224.44
Close
212.44
High
225.08
Low
211.95
Previous Close
222.87
Daily Price Gain
-10.43
YTD High
287.53
YTD High Date
Jan 3, 2022
YTD Low
193.62
YTD Low Date
Jan 28, 2022
YTD Price Change
-71.54
YTD Gain
-25.19%
52 Week High
315.00
52 Week High Date
May 5, 2021
52 Week Low
193.62
52 Week Low Date
Jan 28, 2022
52 Week Price Change
-51.31
52 Week Gain
-19.45%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 6. 2017
67.90
Jan 27. 2017
72.51
14 Trading Days
6.78%
Link
LONG
Oct 17. 2017
93.55
Nov 15. 2017
105.02
21 Trading Days
12.27%
Link
LONG
Jan 19. 2018
91.35
Feb 1. 2018
98.19
9 Trading Days
7.49%
Link
LONG
Feb 23. 2018
102.15
Mar 23. 2018
120.39
20 Trading Days
17.85%
Link
LONG
May 1. 2018
127.75
Jun 7. 2018
158.30
26 Trading Days
23.91%
Link
LONG
Aug 27. 2018
130.80
Sep 21. 2018
149.92
18 Trading Days
14.62%
Link
LONG
Jan 30. 2019
142.93
Feb 19. 2019
151.27
13 Trading Days
5.84%
Link
LONG
Mar 12. 2019
144.76
Mar 27. 2019
152.13
11 Trading Days
5.09%
Link
LONG
Jun 3. 2019
144.32
Jun 26. 2019
164.09
17 Trading Days
13.70%
Link
LONG
Oct 18. 2019
147.21
Nov 8. 2019
157.51
15 Trading Days
7.00%
Link
LONG
Jul 17. 2020
196.50
Aug 20. 2020
232.49
24 Trading Days
18.32%
Link
LONG
Oct 21. 2020
219.41
Nov 9. 2020
245.64
13 Trading Days
11.96%
Link
LONG
Jan 5. 2021
184.28
Feb 2. 2021
244.53
19 Trading Days
32.70%
Link
LONG
Jun 2. 2021
253.56
Jun 16. 2021
271.39
10 Trading Days
7.03%
Link
LONG
Dec 21. 2021
259.66
Jan 4. 2022
277.22
9 Trading Days
6.76%
Link
Company Information
Stock Symbol
PEN
Exchange
NYSE
Company URL
http://www.penumbrainc.com
Company Phone
(510) 995-2486
CEO
Adam Elsesser
Headquarters
California
Business Address
ONE PENUMBRA PLACE, ALAMEDA, CA 94502
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001321732
About

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It focuses on developing products for use by the specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists, and vascular surgeons. Its products are designed to address ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Description

Markets devices for neuro and peripheral vascular conditions and diseases.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading